Effectiveness of pregabalin on chronic nonbacterial prostatitis
- Conditions
- Chronic nonbacterial prostatitis.Other inflammatory diseases of prostate
- Registration Number
- IRCT2016022225507N2
- Lead Sponsor
- Vice Chancellor for Research of Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 288
1) Age over 18 years; 2) no prior history of other urinary system disorders such as urinary tract stones, neurogenic bladder, and urinary infections; 3) no history of major underlying diseases such as cirrhosis, renal failure, diabetes, or hypertension; 4) normal levels of urine, fasting blood sugar (FBS), and creatinine; 5) normal results on the first neurological examination of the perineal area, lower limbs, lower limb reflexes, and bulbocavernosus reflex; 6) no use of other medicines; 7) no signs of psychological disorders; 8) confirmed diagnosis of chronic prostatitis; 9) non-sensitivity to anti-epileptic drugs, pregabalin, thiazolidinediones, or other anti-diabetic agents.
Exclusion criteria: 1) Unwillingness to continue the study, and 2) major side-effects due to the use of medications.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rang of pain. Timepoint: 6 weeks after therapy. Method of measurement: NIH-CPSI scoring system, Scoring from 0 to 21.
- Secondary Outcome Measures
Name Time Method rinary symptoms. Timepoint: 6 weeks after therapy. Method of measurement: NIH-CPSI scoring system, Scoring from 0 to 10.